Magnetic Resonance Spectroscopic Imaging
Magnetic Resonance Spectroscopic Imaging is a medical procedure with 33 clinical trials. Currently 11 active trials ongoing. Historical success rate of 76.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
6
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
52.6%
10 of 19 finished
47.4%
9 ended early
11
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
Clinical Trials (33)
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
Assessing Neuroinflammation in GWI Using MRS
MRSI Evaluation for Minor Stroke With Large Vessel Occlusion
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors
Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 33